Michael Amoroso insider trades

Open-market stock purchases and sales by Michael Amoroso, President and CEO at Precision Biosciences Inc, from SEC Form 4 filings since Nov 2, 2020.

Recent trades

DateStockTradeValue
Jun 1, 2026DTIL Precision Biosciences IncBought (not open market)—
Feb 18, 2026DTIL Precision Biosciences IncSold$78.9K
Feb 17, 2026DTIL Precision Biosciences IncBought (not open market)—
Jan 26, 2026ABEO Abeona Therapeutics IncBought (not open market)—
Jan 22, 2026DTIL Precision Biosciences IncSold$145K
Jan 20, 2026DTIL Precision Biosciences IncBought (not open market)—
Jan 20, 2026DTIL Precision Biosciences IncBought (not open market)—
Jan 20, 2026DTIL Precision Biosciences IncBought (not open market)—
Nov 3, 2025DTIL Precision Biosciences IncBought (not open market)—
Nov 3, 2025DTIL Precision Biosciences IncSold$22.1K
Nov 2, 2025DTIL Precision Biosciences IncBought (not open market)—

Companies traded

  • DTIL Precision Biosciences Inc: 11 sales, last Jun 1, 2026
  • ABEO Abeona Therapeutics Inc: 7 sales, last Jan 26, 2026

Get free alerts when Michael Amoroso files a new trade →